fbpx
Photo: Misset
Photo: Misset

Prof Rudolf Krska: The challenges and trends in mycotoxins

dsm-firmenich
dsm-firmenich Partner profile
28-08-2023 | Updated on 05-07 | |
Photo: Misset
Photo: Misset

What are the latest challenges and trends in mycotoxin analyses? “One of the latest developments the last 5 to 10 years was biomarker analysis,” according to Professor Rudolf Krska.

Rudolf Krska is a professor at the University of Natural Resources and Life Sciences Vienna at the Department of Agrobiotechnology. In this episode of Future Feed Talks we discuss the latest developments in mycotoxins and food safety globally.
 
Watch the full interview below!
 
Do you prefer to listen to the interviews? Subscribe then to the Future Feed Talks podcast platforms:

 

Join 26,000+ subscribers

Subscribe to our newsletter to stay updated about all the need-to-know content in the feed sector, three times a week.
More about
dsm-firmenich
dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich  

Related articles
dsm-firmenich
dsm-firmenich Partner profile

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life™ every day, everywhere, for billions of people. More about dsm-firmenich